Thalassemia Market Size to Reach at a CAGR of 11.2% by 2025 with Market Key Players - Bluebird bio Inc, Acceleron Pharma Inc, Celgene Corporation, GlaxoSmithKline plc, Incyte Corporation, Gamida Cell, La Jolla Pharmaceutical Company, Kiadis Pharma, and IO

Thalassemia Market Size and Growth Rate:

The global thalassemia market size was valued at USD 1.72 billion in 2017 and is assessed to expand at a CAGR of 11.2% to reach USD 3.53 billion by 2025 during the forecast period 2018-2025.

Browse 90 Pages of Research Report developed on the Thalassemia Market @ https://www.researchcosmos.com/reports/global-thalassemia-market-size-status-and-forecast-2025/9393996

Thalassemia Market Overview:

Thalassemia is a precise genetic blood disorder which produces an abnormal form of hemoglobin in the body. This genetic blood disorder leads to the creation of a large number of red blood cells that are unceasingly destroyed, which further leads to a serious condition called anemia. The two types of proteins present in the blood of thalassemia patients are alpha globin and beta globin. While alpha thalassemia occurs chiefly in people living in Southeast Asia, the Middle East, China, and Africa, beta thalassemia is more common among people in the Mediterranean origin, and to a lesser extent in people in China, other Asians, and African Americans.

Thalassemia Market Growth Drivers and Restraints:

The mounting increase in demand for a universal cure, rise in awareness about the disease, and technological advancements are expected to increase the adoption of various forms of therapy like the gene therapies. However, despite technological advancements, there is still an unmet need for a dependable treatment option. Treatment of thalassemia is greatly limited to regular blood transfusions and iron chelation therapy. Drugs that are prescribed for thalassemia mostly cure symptoms and side effects such as anemia, iron overload, and vitamin deficiency.

However, a new form of therapy called gene therapy is currently evolving as a reliable treatment option for the disease. In spite of this, stringent regulatory policies, and the high cost of treatment is anticipated to hinder the growth of thalassemia market.

For Free Sample of the Report @ https://www.researchcosmos.com/request/global-thalassemia-market-size-status-and-forecast-2025/9393996

Thalassemia Market Geographical Segmentation:

Geographically, the global market has been branched into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The disease is most common in Greece, coastal regions of Turkey, some parts of Italy, major Mediterranean islands such as Cyprus, and South Asian countries such as Maldives and India. In the U.S. especially, thalassemia is considered as an orphan or rare disease, affecting less than 20,000 people.

The occurrence of the disease is reported to increase progressively over the years across different regions and this can be credited to population migration, intermarriages, and genetic and environmental factors warning the condition and its implications and treatments. Various companies are now adopting the strategy of acquisition and collaboration with parallel companies to improve and strengthen geographic presence in the international market. The partnership pact between companies is expected to increase in the number of clinical trials for thalassemia in the near future.

Key players of the Thalassemia Market:

Some of the firms which are prominent in this industry in the treatment of this disease include Bluebird bio Inc, Acceleron Pharma Inc, Celgene Corporation, GlaxoSmithKline plc, Incyte Corporation, Gamida Cell, La Jolla Pharmaceutical Company, Kiadis Pharma, and IONIS Pharmaceuticals.

For Any Queries Inquire More @ https://www.researchcosmos.com/inquire/global-thalassemia-market-size-status-and-forecast-2025/9393996

Research Cosmos is a provider of standard and customized market research, business intelligence and consulting services across more than 100 domains in different industries of the world. We host the trending market reports of the world’s top-notch publishing companies, offering services to a wide range of customers from students to fortune 500 companies and discloses the hidden opportunities in every leading industry of the world.

Kevin Stewart
Global Sales Manager
Research Cosmos
www.researchcosmos.com
Blog: https://acutemarketinsights.com
Blog: https://marketreportsweb.com/

This release was published on openPR.